Bridgeway Capital Management’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,270
| Closed | -$57.9K | – | 1320 |
|
|
2024
Q1 | $57.9K | Hold |
12,270
| – | – | ﹤0.01% | 1258 |
|
|
2023
Q4 | $56.4K | Sell |
12,270
-3,800
| -24% | -$17.5K | ﹤0.01% | 1300 |
|
|
2023
Q3 | $41.8K | Hold |
16,070
| – | – | ﹤0.01% | 1316 |
|
|
2023
Q2 | $77.7K | Sell |
16,070
-7,000
| -30% | -$33.8K | ﹤0.01% | 1291 |
|
|
2023
Q1 | $152K | Buy |
23,070
+5,200
| +29% | +$34.3K | ﹤0.01% | 1157 |
|
|
2022
Q4 | $198K | Buy |
17,870
+2,500
| +16% | +$27.8K | 0.01% | 1091 |
|
|
2022
Q3 | $114K | Hold |
15,370
| – | – | ﹤0.01% | 1253 |
|
|
2022
Q2 | $92K | Buy |
+15,370
| New | +$92K | ﹤0.01% | 1237 |
|